Blocking IL-1beta and also IL-1alpha in a Broad Spectrum of Diseases
Il 14/04/2014 ore 14.30 - 15.30
Aula Conferenze, CNR Via P. Castellino, 111 80131 Napoli
Prof. Charles A. Dinarello is considered one of the founding fathers of cytokines having purified and cloned interleukin 1. This important step established the validation of cytokines as mediators of disease, particularly of inflammation. Current studies blocking IL-1 in humans supports Dinarello's and his co-workers pivotal contributions to cytokine biology and the pathogenesis of inflammatory diseases.
Dinarello is a professor of medicine currently at the University of Colorado at Denver. He is an expert on inflammatory cytokines, specifically Interleukin 1. Dinarello received his Doctor of Medicine in 1969 at Yale University and since 1996, he is Professor of Medicine at University of Colorado School of Medicine. He is also Professor of Experimental Medicine at the Radboud University Medical Center in Nijmegen, The Netherlands.
He is fluent in English, Italian and German.
Awards
- 1993, Ernst Jung Prize
- The 2009 Albany Medical Cneter Prize (Shared with Ralph M. Steinman and Bruce A. Beutler)
- 2006, Hamdan Award for Medical Research Excellence, awarded by Sheik Hamdan bin Rashid Al Maktoum Award for Medical Sciences, Dubai, United Arab Emirates
- 2009, together with Tadamitsu Kishimoto and Toshio Hirano: Crafoord Prize in Polyarthritis for “for their pioneering work to isolate interleukins, determine their properties and explore their role in the onset of inflammatory diseases”.
- 2010: Paul Ehrlich and Ludwig Darmstaedter Prize
- 2010: Novartis Prize in Clinical Immunology together with Juerg Tschopp.
Organizzato da:
IBP, CNR
Referente organizzativo:
Diana Boraschi
CNR - Istituto di biochimica delle proteine
Via P. Castellino, 111 80131 Napoli
d.boraschi@ibp.cnr.it
081/6132273
Modalità di accesso: ingresso libero
Vedi anche: